Skip to main content

Ongoing FDAEvent 99525 (1 month ago)

AVID Medical Halyard IV Start Kits

The Halyard IV Start Kit lacks sterility assurance due to wrinkles in the paper lidding that may breach the seal area.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

AVID Medical, Inc., of Toano, Virginia, recalled Halyard IV Start Kit Non-Sterile REF: KRIV26-02 because the convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators that lack sterility assurance due to wrinkles in the paper lidding which may breach the seal area. The recall began July 14, 2026, and was added to the FDA's Enforcement Report on September 4, 2026.

The recalled kits were distributed in the state of Nebraska. The FDA classified the recall on September 4, 2026, and in the FDA's weekly enforcement report on September 16, 2026.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is your kit affected?

Match the UDI-DI and lot code listed under your product.

  1. Halyard IV Start Kit Non-Sterile REF: KRIV26-02

    UDI-DI
    • 10809160460481
    Lot
    • 1658438

Details

Company began the recall
Sold in

US Nationwide distribution in the state of Nebraska.

Event ID
99525
Recall No.
Z-3109-2026
Company
AVID Medical, Inc.Toano, Virginia
Quantity recalled
98 Kits
Recall type
Voluntary: Firm initiated
Customers told by
E-Mail
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

All recalls from AVID Medical, Inc.

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration